Home › Chronic Progressive Multiple Sclerosis › California
Chronic Progressive Multiple Sclerosis clinical trials in California
10 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in California.
Cities in California
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Fullerton Neurology and Headache Center, Fullerton
- Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed)), Torrance
- Regina Berkovich MD, PhD Inc, West Hollywood
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 23, 2026 · NCT07299019A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Regina Berkovich MD, PhD Inc., West Hollywood
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 22, 2026 · NCT07067463Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- UC San Diego, La Jolla
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Stanford Multiple Sclerosis Center, Palo Alto
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Sep 16, 2026 · NCT04047628A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Fullerton Neuro and Headache Ctr, Fullerton
- Regina Berkovich MD PhD Inc, West Hollywood
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Sandler Neurosciences Building, Neurological Clinical Research Unit, San Francisco
RecruitingPhase 1/2
Ages 18 to 55 · All sexes · Updated Jul 2, 2026 · NCT05359653Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
- Stanford University, Redwood City
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Mar 23, 2026 · NCT07139743A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
- Stanford Multiple Sclerosis Center, Palo Alto
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT06138132"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
- University of California, San Francisco, San Francisco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT07222618MS-ResearchBiomarkerS
- Cedars-Sinai Medical Center, Los Angeles
RecruitingObservational studyHealthy volunteers welcomeMentions payment for participants
Ages 18 and older · All sexes · Updated Feb 6, 2024 · NCT05204459From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.